Great expectations: the placebo effect in Parkinson's disease.
Identifieur interne : 000732 ( PubMed/Checkpoint ); précédent : 000731; suivant : 000733Great expectations: the placebo effect in Parkinson's disease.
Auteurs : Sarah Christine Lidstone [Canada]Source :
- Handbook of experimental pharmacology [ 0171-2004 ] ; 2014.
English descriptors
- KwdEn :
- MESH :
- chemical , secretion : Dopamine.
- metabolism : Parkinson Disease.
- psychology : Parkinson Disease.
- therapy : Parkinson Disease.
- Humans, Neuroimaging, Placebo Effect, Reward.
Abstract
Our understanding of the neural mechanisms underlying the placebo effect has increased exponentially in parallel with the advances in brain imaging. This is of particular importance in the field of Parkinson's disease, where clinicians have described placebo effects in their patients for decades. Significant placebo effects have been observed in clinical trials for medications as well as more invasive surgical trials including deep-brain stimulation and stem-cell implantation. In addition to placebo effects occurring as a byproduct of randomized controlled trials, investigation of the placebo effect itself in the laboratory setting has further shown the capacity for strong placebo effects within this patient population. Neuroimaging studies have demonstrated that placebos stimulate the release of dopamine in the striatum of patients with Parkinson's disease and can alter the activity of dopamine neurons using single-cell recording. When taken together with the findings from other medical conditions discussed elsewhere in this publication, a unified mechanism for the placebo effect in Parkinson's disease is emerging that blends expectation-induced neurochemical changes and disease-specific nigrostriatal dopamine release.
DOI: 10.1007/978-3-662-44519-8_8
PubMed: 25304530
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:25304530Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Great expectations: the placebo effect in Parkinson's disease.</title>
<author><name sortKey="Lidstone, Sarah Christine" sort="Lidstone, Sarah Christine" uniqKey="Lidstone S" first="Sarah Christine" last="Lidstone">Sarah Christine Lidstone</name>
<affiliation wicri:level="4"><nlm:affiliation>Neurology Residency Program, University of Toronto, Toronto, ON, Canada, lidstone@interchange.ubc.ca.</nlm:affiliation>
<country wicri:rule="url">Canada</country>
<wicri:regionArea>Neurology Residency Program, University of Toronto, Toronto, ON, Canada</wicri:regionArea>
<orgName type="university">Université de Toronto</orgName>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2014">2014</date>
<idno type="RBID">pubmed:25304530</idno>
<idno type="pmid">25304530</idno>
<idno type="doi">10.1007/978-3-662-44519-8_8</idno>
<idno type="wicri:Area/PubMed/Corpus">000806</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000806</idno>
<idno type="wicri:Area/PubMed/Curation">000806</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000806</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000806</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000806</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Great expectations: the placebo effect in Parkinson's disease.</title>
<author><name sortKey="Lidstone, Sarah Christine" sort="Lidstone, Sarah Christine" uniqKey="Lidstone S" first="Sarah Christine" last="Lidstone">Sarah Christine Lidstone</name>
<affiliation wicri:level="4"><nlm:affiliation>Neurology Residency Program, University of Toronto, Toronto, ON, Canada, lidstone@interchange.ubc.ca.</nlm:affiliation>
<country wicri:rule="url">Canada</country>
<wicri:regionArea>Neurology Residency Program, University of Toronto, Toronto, ON, Canada</wicri:regionArea>
<orgName type="university">Université de Toronto</orgName>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j">Handbook of experimental pharmacology</title>
<idno type="ISSN">0171-2004</idno>
<imprint><date when="2014" type="published">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Dopamine (secretion)</term>
<term>Humans</term>
<term>Neuroimaging</term>
<term>Parkinson Disease (metabolism)</term>
<term>Parkinson Disease (psychology)</term>
<term>Parkinson Disease (therapy)</term>
<term>Placebo Effect</term>
<term>Reward</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="secretion" xml:lang="en"><term>Dopamine</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Humans</term>
<term>Neuroimaging</term>
<term>Placebo Effect</term>
<term>Reward</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Our understanding of the neural mechanisms underlying the placebo effect has increased exponentially in parallel with the advances in brain imaging. This is of particular importance in the field of Parkinson's disease, where clinicians have described placebo effects in their patients for decades. Significant placebo effects have been observed in clinical trials for medications as well as more invasive surgical trials including deep-brain stimulation and stem-cell implantation. In addition to placebo effects occurring as a byproduct of randomized controlled trials, investigation of the placebo effect itself in the laboratory setting has further shown the capacity for strong placebo effects within this patient population. Neuroimaging studies have demonstrated that placebos stimulate the release of dopamine in the striatum of patients with Parkinson's disease and can alter the activity of dopamine neurons using single-cell recording. When taken together with the findings from other medical conditions discussed elsewhere in this publication, a unified mechanism for the placebo effect in Parkinson's disease is emerging that blends expectation-induced neurochemical changes and disease-specific nigrostriatal dopamine release.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25304530</PMID>
<DateCreated><Year>2014</Year>
<Month>10</Month>
<Day>11</Day>
</DateCreated>
<DateCompleted><Year>2015</Year>
<Month>02</Month>
<Day>05</Day>
</DateCompleted>
<DateRevised><Year>2014</Year>
<Month>10</Month>
<Day>11</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0171-2004</ISSN>
<JournalIssue CitedMedium="Print"><Volume>225</Volume>
<PubDate><Year>2014</Year>
</PubDate>
</JournalIssue>
<Title>Handbook of experimental pharmacology</Title>
<ISOAbbreviation>Handb Exp Pharmacol</ISOAbbreviation>
</Journal>
<ArticleTitle>Great expectations: the placebo effect in Parkinson's disease.</ArticleTitle>
<Pagination><MedlinePgn>139-47</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/978-3-662-44519-8_8</ELocationID>
<Abstract><AbstractText>Our understanding of the neural mechanisms underlying the placebo effect has increased exponentially in parallel with the advances in brain imaging. This is of particular importance in the field of Parkinson's disease, where clinicians have described placebo effects in their patients for decades. Significant placebo effects have been observed in clinical trials for medications as well as more invasive surgical trials including deep-brain stimulation and stem-cell implantation. In addition to placebo effects occurring as a byproduct of randomized controlled trials, investigation of the placebo effect itself in the laboratory setting has further shown the capacity for strong placebo effects within this patient population. Neuroimaging studies have demonstrated that placebos stimulate the release of dopamine in the striatum of patients with Parkinson's disease and can alter the activity of dopamine neurons using single-cell recording. When taken together with the findings from other medical conditions discussed elsewhere in this publication, a unified mechanism for the placebo effect in Parkinson's disease is emerging that blends expectation-induced neurochemical changes and disease-specific nigrostriatal dopamine release.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lidstone</LastName>
<ForeName>Sarah Christine</ForeName>
<Initials>SC</Initials>
<AffiliationInfo><Affiliation>Neurology Residency Program, University of Toronto, Toronto, ON, Canada, lidstone@interchange.ubc.ca.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>Germany</Country>
<MedlineTA>Handb Exp Pharmacol</MedlineTA>
<NlmUniqueID>7902231</NlmUniqueID>
<ISSNLinking>0171-2004</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>VTD58H1Z2X</RegistryNumber>
<NameOfSubstance UI="D004298">Dopamine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D004298" MajorTopicYN="N">Dopamine</DescriptorName>
<QualifierName UI="Q000557" MajorTopicYN="N">secretion</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D059906" MajorTopicYN="N">Neuroimaging</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
<QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015990" MajorTopicYN="Y">Placebo Effect</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012201" MajorTopicYN="N">Reward</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year>
<Month>10</Month>
<Day>12</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2014</Year>
<Month>10</Month>
<Day>12</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2015</Year>
<Month>2</Month>
<Day>6</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">25304530</ArticleId>
<ArticleId IdType="doi">10.1007/978-3-662-44519-8_8</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Canada</li>
</country>
<region><li>Ontario</li>
</region>
<settlement><li>Toronto</li>
</settlement>
<orgName><li>Université de Toronto</li>
</orgName>
</list>
<tree><country name="Canada"><region name="Ontario"><name sortKey="Lidstone, Sarah Christine" sort="Lidstone, Sarah Christine" uniqKey="Lidstone S" first="Sarah Christine" last="Lidstone">Sarah Christine Lidstone</name>
</region>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000732 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000732 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Canada |area= ParkinsonCanadaV1 |flux= PubMed |étape= Checkpoint |type= RBID |clé= pubmed:25304530 |texte= Great expectations: the placebo effect in Parkinson's disease. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:25304530" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \ | NlmPubMed2Wicri -a ParkinsonCanadaV1
This area was generated with Dilib version V0.6.29. |